Heparan sulfate targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors

References

• Aggarwal P, Hall JB, McLeland CB, et al. (2009). Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61:428–37.
   PubMed Web of Science ®Google Scholar
• Alhareth K, Vauthier C, Gueutin C, et al. (2012). HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles. J Chromatogr B Analyt Technol Biomed Life Sci 887–888:128–32.
   PubMed Web of Science ®Google Scholar
• Allen TM, Sapra P, Moase E. (2002). Use of the post-insertion method for the formation of ligand-coupled liposomes. Cell Mol Biol Lett 7:889–94.
   PubMed Web of Science ®Google Scholar
• Amin M, Bagheri M, Mansourian M, et al. (2018). Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells. Int J Nanomedicine 13:7441–55.
   PubMed Web of Science ®Google Scholar
• Bartczak D, Nitti S, Millar TM, et al. (2012). Exocytosis of peptide functionalized gold nanoparticles in endothelial cells. Nanoscale 4:4470–2.
   PubMed Web of Science ®Google Scholar
• Bechara C, Pallerla M, Zaltsman Y, et al. (2013). Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis. FASEB J 27:738–49.
   PubMed Web of Science ®Google Scholar
• Berry L, Andrew M, Post M, et al. (1991). A549 lung epithelial cells synthesize anticoagulant molecules on the cell surface and matrix and in conditioned media. Am J Respir Cell Mol Biol 4:338–46.
   PubMed Web of Science ®Google Scholar
• Bigdeli A, Palchetti S, Pozzi D, et al. (2016). Exploring cellular interactions of liposomes using protein corona fingerprints and physicochemical properties. ACS Nano 10:3723–37.
   PubMed Web of Science ®Google Scholar
• Bremnes RM, Dønnem T, Al-Saad S, et al. (2011). The role of tumor stroma in cancer progression and prognosis emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol 6:209–17.
   PubMed Web of Science ®Google Scholar
• Cedervall T, Lynch I, Foy M, et al. (2007). Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl 46:5754–6.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Tsai KC, Kuo PH, et al. (2015). A heparan sulfate-binding cell penetrating peptide for tumor targeting and migration inhibition. Biomed Res Int 2015:1–15.
   Web of Science ®Google Scholar
• Cheng L, Montironi R, Davidson DD, et al. (2009). Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol 22:S70–S95.
   PubMed Web of Science ®Google Scholar
• Christianson HC, Belting M. (2014). Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. Matrix Biol 35:51–5.
   PubMed Web of Science ®Google Scholar
• Corbo C, Molinaro R, Tabatabaei M, et al. (2017). Personalized protein corona on nanoparticles and its clinical implications. Biomater Sci 5:378–87.
   PubMed Web of Science ®Google Scholar
• Dalal C, Jana NR. (2017). Multivalency effect of TAT-peptide-functionalized nanoparticle in cellular endocytosis and subcellular trafficking. J Phys Chem B 121:2942–51.
   PubMed Web of Science ®Google Scholar
• Demoy M, Andreux JP, Weingarten C, et al. (1999). In vitro evaluation of nanoparticles spleen capture. Life Sci 64:1329–37.
   PubMed Web of Science ®Google Scholar
• Duchesne L, Octeau V, Bearon RN, et al. (2012). Transport of fibroblast growth factor 2 in the pericellular matrix is controlled by the spatial distribution of its binding sites in heparan sulfate. PLoS Biol 10:e1001361.
   PubMed Web of Science ®Google Scholar
• Fang Sl, Fan TC, Fu HW, et al. (2013). A novel cell-penetrating peptide derived from human eosinophil cationic protein. PLoS One 8:e57318.
   PubMed Web of Science ®Google Scholar
• Filonov GS, Piatkevich KD, Ting LM, et al. (2011). Bright and stable near-infrared fluorescent protein for in vivo imaging. Nat Biotechnol 29:757–61.
   PubMed Web of Science ®Google Scholar
• Fu LS, Wu YR, Fang SL, et al. (2017). Cell penetrating peptide derived from human eosinophil cationic protein decreases airway allergic inflammation. Sci Rep 7:12352.
   PubMed Web of Science ®Google Scholar
• Fuster MM, Wang L. (2010). Endothelial heparan sulfate in angiogenesis. Prog Mol Biol Transl Sci 93:179–212.
   PubMed Web of Science ®Google Scholar
• Greish K. (2010). Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol 624:25–37.
   PubMedGoogle Scholar
• Hayashida K, Stahl PD, Park PW. (2008). Syndecan-1 ectodomain shedding is regulated by the small GTPase Rab5. J Biol Chem 283:35435–44.
   PubMed Web of Science ®Google Scholar
• He X, Chen X, Liu L, et al. (2018). Sequentially triggered nanoparticles with tumor penetration and intelligent drug release for pancreatic cancer therapy. Adv Sci (Weinh) 5:1701070.
   PubMedGoogle Scholar
• Hodkinson PS, Mackinnon AC, Sethi T. (2007). Extracellular matrix regulation of drug resistance in small-cell lung cancer. Int J Radiat Biol 83:733–41.
   PubMed Web of Science ®Google Scholar
• Hoshyar N, Gray S, Han H, et al. (2016). The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine (Lond) 11:673–92.
   PubMed Web of Science ®Google Scholar
• Hu C, Cun X, Ruan S, et al. (2018). Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy. Biomaterials 168:64–75.
   PubMed Web of Science ®Google Scholar
• Huang S, Shao K, Kuang Y, et al. (2013). Tumor targeting and microenvironment-responsive nanoparticles for gene delivery. Biomaterials 34:5294–302.
   PubMed Web of Science ®Google Scholar
• Hung LC, Jiang I, Chen CJ, et al. (2017). Heparin-promoted cellular uptake of the cell-penetrating glycosaminoglycan binding peptide, GBPECP, depends on a single tryptophan. ACS Chem Biol 12:398–406.
   PubMed Web of Science ®Google Scholar
• Ishida T, Ichihara M, Wang XYu, et al. (2006). Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. J Control Release 115:243–50.
   PubMed Web of Science ®Google Scholar
• Jobin ML, Blanchet M, Henry S, et al. (2015). The role of tryptophans on the cellular uptake and membrane interaction of arginine-rich cell penetrating peptides. Biochim Biophys Acta 1848:593–602.
   PubMed Web of Science ®Google Scholar
• Jobin ML, Bonnafous P, Temsamani H, et al. (2013). The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: toward an understanding of its selectivity for cancer cells. Biochim Biophys Acta 1828:1457–70.
   PubMed Web of Science ®Google Scholar
• Kawahara R, Granato DC, Carnielli CM, et al. (2014). Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. PLoS One 9:e115004.
   PubMed Web of Science ®Google Scholar
• Keeratichamroen S, Lirdprapamongkol K, Svasti J. (2018). Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells. Oncol Rep 39:1765–74.
   PubMed Web of Science ®Google Scholar
• Koren E, Torchilin VP. (2012). Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 18:385–93.
   PubMed Web of Science ®Google Scholar
• Lee H, Fonge H, Hoang B, et al. (2010). The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol Pharmaceutics 7:1195–208.
   PubMed Web of Science ®Google Scholar
• Lee SW, Kwak HS, Kang MH, et al. (2018). Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid. Sci Rep 8:2365.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang J, Wientjes MG, et al. (2012). Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. Adv Drug Deliv Rev 64:29–39.
   PubMed Web of Science ®Google Scholar
• Lien PC, Kuo PH, Chen CJ, et al. (2013). In silico prediction and in vitro characterization of multifunctional human RNase3. Biomed Res Int 2013:1–12.
   Web of Science ®Google Scholar
• Liu R, Hu C, Yang Y, et al. (2019). Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B 9:410–20.
   PubMed Web of Science ®Google Scholar
• Lynch I, Salvati A, Dawson KA. (2009). Protein-nanoparticle interactions: What does the cell see? Nature Nanotech 4:546–7.
   PubMed Web of Science ®Google Scholar
• Maeshima AM, Niki T, Maeshima A, et al. (2002). Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma. Cancer 95:2546–54.
   PubMed Web of Science ®Google Scholar
• Marolla APC, Waisberg J, Saba GT, et al. (2015). Glycomics expression analysis of sulfated glycosaminoglycans of human colorectal cancer tissues and non-neoplastic mucosa by electrospray ionization mass spectrometry. Einstein (Sao Paulo) 13:510–7.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–92.
   PubMed Web of Science ®Google Scholar
• Monopoli MP, Walczyk D, Campbell A, et al. (2011). Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525–34.
   PubMed Web of Science ®Google Scholar
• Murakami D, Takamori S, Kawahara A, et al. (2018). Periostin expression in non-small cell lung cancer: clinical significance. Kurume Med J 64:13–20.
   PubMedGoogle Scholar
• Naba A, Clauser KR, Hoersch S, et al. (2012). The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics 11:M111 014647.
   PubMed Web of Science ®Google Scholar
• Nam EJ, Park PW. (2012). Shedding of cell membrane-bound proteoglycans. Methods Mol Biol 836:291–305.
   PubMedGoogle Scholar
• Nishihara H. (2014). Human pathological basis of blood vessels and stromal tissue for nanotechnology. Adv Drug Deliv Rev 74:19–27.
   PubMed Web of Science ®Google Scholar
• Oh N, Park JH. (2014). Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine 9 Suppl 1:51–63.
   PubMed Web of Science ®Google Scholar
• Payne CK, Jones SA, Chen C, et al. (2007). Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands. Traffic 8:389–401.
   PubMed Web of Science ®Google Scholar
• Pozzi D, Caracciolo G, Digiacomo L, et al. (2015). The biomolecular corona of nanoparticles in circulating biological media. Nanoscale 7:13958–66.
   PubMed Web of Science ®Google Scholar
• Priwitaningrum DL, Blondé JBG, Sridhar A. (2016). Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration. J Control Release 244:257–68.
   Google Scholar
• Rangel MP, de Sá VK, Prieto T, et al. (2018). Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer. Glycoconj J 35:233–42.
   PubMed Web of Science ®Google Scholar
• Rivest V, Phivilay A, Julien C, et al. (2007). Novel liposomal formulation for targeted gene delivery. Pharm Res 24:981–90.
   PubMed Web of Science ®Google Scholar
• Rodriguez PL, Harada T, Christian DA, et al. (2013). Minimal “Self” peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 339:971–5.
   PubMed Web of Science ®Google Scholar
• Rydberg HA, Matson M, Åmand HL, et al. (2012). Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides. Biochemistry 51:5531–9.
   PubMed Web of Science ®Google Scholar
• Sacchetti C, Motamedchaboki K, Magrini A, et al. (2013). Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. ACS Nano 7:1974–89.
   PubMed Web of Science ®Google Scholar
• Saha K, Rahimi M, Yazdani M, et al. (2016). Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano 10:4421–30.
   PubMed Web of Science ®Google Scholar
• Sarrazin S, Lamanna WC, Esko JD. (2011). Heparan sulfate proteoglycans. Cold Spring Harbor Perspect Biol 3:a004952.
   PubMed Web of Science ®Google Scholar
• Scherzer MT, Waigel S, Donninger H, et al. (2015). Fibroblast-derived extracellular matrices: an alternative cell culture system that increases metastatic cellular properties. PLoS One 10:e0138065.
   PubMed Web of Science ®Google Scholar
• Stylianopoulos T, Poh MZ, Insin N, et al. (2010). Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. Biophys J 99:1342–9.
   PubMed Web of Science ®Google Scholar
• Sugahara KN, Teesalu T, Karmali PP, et al. (2009). Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 16:510–20.
   PubMed Web of Science ®Google Scholar
• Sun C, et al. (2016). Selectivity in glycosaminoglycan binding dictates the distribution and diffusion of fibroblast growth factors in the pericellular matrix. Open Biol 6:150277.
   PubMed Web of Science ®Google Scholar
• Teesalu T, Sugahara KN, Kotamraju VR, et al. (2009). C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A 106:16157–62.
   PubMed Web of Science ®Google Scholar
• Ter-Avetisyan G, Tünnemann G, Nowak D, et al. (2009). Cell entry of arginine-rich peptides is independent of endocytosis. J Biol Chem 284:3370–8.
   PubMed Web of Science ®Google Scholar
• Tjomsland V, Niklasson L, Sandström P, et al. (2011). The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma. Clin Dev Immunol 2011:1–12.
   Google Scholar
• Tsoi KM, MacParland SA, Ma XZ, et al. (2016). Mechanism of hard-nanomaterial clearance by the liver. Nat Mater 15:1212–21.
   PubMed Web of Science ®Google Scholar
• Verhoef JJF, Anchordoquy TJ. (2013). Questioning the use of PEGylation for drug delivery. Drug Deliv Transl Res 3:499–503.
   PubMed Web of Science ®Google Scholar
• Xiao W, Xiong J, Zhang S, et al. (2018). Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability. Int J Pharm 538:105–11.
   PubMed Web of Science ®Google Scholar
• Xu F, Reiser M, Yu X, et al. (2016). Lipid-mediated targeting with membrane-wrapped nanoparticles in the presence of corona formation. ACS Nano 10:1189–200.
   PubMed Web of Science ®Google Scholar
• Yamashita M, Ogawa T, Zhang X, et al. (2012). Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome. Breast Cancer 19:170–6.
   PubMed Web of Science ®Google Scholar
• Yang S, Gao H. (2017). Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy. Pharmacol Res 126:97–108.
   PubMed Web of Science ®Google Scholar
• Zhang B, Shen S, Liao Z, et al. (2014). Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles. Biomaterials 35:4088–98.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu T, Yu W, et al. (2018). Ligand size and conformation affect the behavior of nanoparticles coated with in vitro and in vivo protein corona. ACS Appl Mater Interfaces 10:9094–103.
   PubMed Web of Science ®Google Scholar